Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

0(0%)

Results Posted

120%(6 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_2

43%

Ph phase_1

57%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

4(57.1%)

Phase 2Efficacy & side effects

3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Detailed Status

Completed5

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 2

Trials by Phase

Phase 14 (57.1%)

Phase 23 (42.9%)

Trials by Status

terminated114%

withdrawn114%

completed571%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_1

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

NCT05080660

completedphase_2

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain

NCT05177094

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT04183283Phase 1

A Study of LY3526318 in Healthy Women

Completed

NCT03977974Phase 1

A Study of LY3526318 in Healthy Participants

Terminated

NCT04682119Phase 1

A Safety Study of LY3526318 in Healthy Participants

Completed

NCT05080660Phase 2

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

Completed

NCT05177094Phase 2

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain

Completed

NCT05086289Phase 2

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain

Completed

NCT05580250Phase 1

A Study of LY3526318 in Healthy Male Japanese Participants

Withdrawn

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7